Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOXK1
|
ENSG00000164916.9 | forkhead box K1 |
FOXP2
|
ENSG00000128573.18 | forkhead box P2 |
FOXB1
|
ENSG00000171956.5 | forkhead box B1 |
FOXP3
|
ENSG00000049768.10 | forkhead box P3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_60291951_60292102 | FOXB1 | 4395 | 0.348878 | -0.93 | 2.3e-04 | Click! |
chr15_60387617_60387768 | FOXB1 | 91271 | 0.093270 | 0.92 | 4.3e-04 | Click! |
chr15_60287683_60287834 | FOXB1 | 8663 | 0.310594 | -0.91 | 6.4e-04 | Click! |
chr15_60447653_60447804 | FOXB1 | 151307 | 0.041889 | 0.89 | 1.2e-03 | Click! |
chr15_60297080_60297369 | FOXB1 | 803 | 0.771724 | -0.86 | 2.8e-03 | Click! |
chr7_4764841_4764992 | FOXK1 | 15574 | 0.176702 | -0.88 | 1.6e-03 | Click! |
chr7_4721627_4721778 | FOXK1 | 238 | 0.935677 | -0.87 | 2.4e-03 | Click! |
chr7_4784246_4784803 | FOXK1 | 4034 | 0.209997 | -0.86 | 2.7e-03 | Click! |
chr7_4786340_4786770 | FOXK1 | 6065 | 0.186338 | -0.81 | 8.4e-03 | Click! |
chr7_4793300_4793471 | FOXK1 | 12895 | 0.159885 | -0.79 | 1.1e-02 | Click! |
chr7_113726623_113727026 | FOXP2 | 209 | 0.957359 | -0.84 | 4.5e-03 | Click! |
chr7_113724698_113724942 | FOXP2 | 1795 | 0.434860 | -0.74 | 2.1e-02 | Click! |
chr7_113724454_113724665 | FOXP2 | 2056 | 0.398549 | -0.70 | 3.6e-02 | Click! |
chr7_114142488_114142639 | FOXP2 | 75993 | 0.100788 | 0.66 | 5.5e-02 | Click! |
chr7_113937787_113937938 | FOXP2 | 116467 | 0.064249 | -0.63 | 6.6e-02 | Click! |
chrX_49121863_49122014 | FOXP3 | 650 | 0.506134 | -0.53 | 1.5e-01 | Click! |
chrX_49115767_49115918 | FOXP3 | 145 | 0.906523 | -0.38 | 3.1e-01 | Click! |
chrX_49121510_49121720 | FOXP3 | 327 | 0.767758 | -0.37 | 3.3e-01 | Click! |
chrX_49114161_49114312 | FOXP3 | 726 | 0.459933 | -0.34 | 3.7e-01 | Click! |
chrX_49114542_49114693 | FOXP3 | 345 | 0.752519 | -0.24 | 5.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_80354102_80354437 | 1.59 |
RP13-20L14.4 |
|
4989 |
0.1 |
chr14_101308246_101309004 | 1.45 |
ENSG00000214548 |
. |
7020 |
0.04 |
chr19_2185273_2185543 | 1.25 |
DOT1L |
DOT1-like histone H3K79 methyltransferase |
21224 |
0.09 |
chr15_68817963_68818114 | 1.13 |
CORO2B |
coronin, actin binding protein, 2B |
53270 |
0.16 |
chr8_49341467_49342503 | 1.07 |
ENSG00000252710 |
. |
121395 |
0.06 |
chr13_27159400_27159551 | 1.06 |
WASF3 |
WAS protein family, member 3 |
27588 |
0.22 |
chr21_35705528_35705679 | 1.06 |
ENSG00000266007 |
. |
28173 |
0.13 |
chr1_226456896_226457047 | 1.02 |
ENSG00000238545 |
. |
34992 |
0.12 |
chr6_166985772_166986271 | 1.01 |
RPS6KA2 |
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
27843 |
0.18 |
chr3_25599465_25599616 | 1.01 |
ENSG00000272166 |
. |
2443 |
0.36 |
chr12_122804044_122804253 | 0.96 |
CLIP1 |
CAP-GLY domain containing linker protein 1 |
41129 |
0.14 |
chr1_210551647_210551798 | 0.95 |
ENSG00000200972 |
. |
4111 |
0.28 |
chr6_148543920_148544071 | 0.93 |
SASH1 |
SAM and SH3 domain containing 1 |
49445 |
0.15 |
chr5_52627609_52627883 | 0.92 |
FST |
follistatin |
148493 |
0.04 |
chr14_33077898_33078049 | 0.90 |
AKAP6 |
A kinase (PRKA) anchor protein 6 |
113695 |
0.07 |
chr4_122059678_122059966 | 0.90 |
TNIP3 |
TNFAIP3 interacting protein 3 |
3232 |
0.3 |
chr13_24246086_24246262 | 0.88 |
AL139080.1 |
Uncharacterized protein |
76069 |
0.1 |
chr5_38925164_38925315 | 0.88 |
OSMR |
oncostatin M receptor |
20739 |
0.26 |
chr2_189540640_189540876 | 0.85 |
GULP1 |
GULP, engulfment adaptor PTB domain containing 1 |
105948 |
0.07 |
chr8_23176400_23176640 | 0.85 |
LOXL2 |
lysyl oxidase-like 2 |
14488 |
0.14 |
chr16_27253790_27254558 | 0.84 |
NSMCE1 |
non-SMC element 1 homolog (S. cerevisiae) |
9775 |
0.17 |
chr6_140399111_140399262 | 0.82 |
ENSG00000252107 |
. |
80645 |
0.11 |
chr19_10529958_10530965 | 0.82 |
CDC37 |
cell division cycle 37 |
336 |
0.7 |
chr20_49440990_49441141 | 0.81 |
BCAS4 |
breast carcinoma amplified sequence 4 |
29458 |
0.14 |
chr10_33411027_33411472 | 0.81 |
ENSG00000263576 |
. |
23685 |
0.21 |
chr7_54878481_54878866 | 0.81 |
SEC61G |
Sec61 gamma subunit |
51006 |
0.13 |
chr5_133461389_133462125 | 0.80 |
TCF7 |
transcription factor 7 (T-cell specific, HMG-box) |
2448 |
0.32 |
chr2_47284202_47284907 | 0.80 |
AC073283.7 |
|
10407 |
0.19 |
chr2_18697309_18697460 | 0.80 |
RDH14 |
retinol dehydrogenase 14 (all-trans/9-cis/11-cis) |
44562 |
0.15 |
chr11_58384003_58384154 | 0.80 |
AP001350.1 |
Uncharacterized protein |
5319 |
0.16 |
chr12_94699131_94699408 | 0.79 |
RP11-1105G2.3 |
Uncharacterized protein |
25313 |
0.14 |
chr17_59385442_59385593 | 0.79 |
RP11-332H18.3 |
|
74629 |
0.08 |
chr6_1820746_1820897 | 0.79 |
FOXC1 |
forkhead box C1 |
210140 |
0.02 |
chr22_28627219_28627370 | 0.78 |
ENSG00000201209 |
. |
1517 |
0.52 |
chr17_28703518_28703669 | 0.78 |
CPD |
carboxypeptidase D |
2330 |
0.23 |
chr3_178071476_178071627 | 0.78 |
LINC01014 |
long intergenic non-protein coding RNA 1014 |
65438 |
0.12 |
chr3_120148715_120148927 | 0.77 |
FSTL1 |
follistatin-like 1 |
21017 |
0.22 |
chr6_90694678_90695035 | 0.77 |
ENSG00000222078 |
. |
16369 |
0.19 |
chr7_92242749_92242922 | 0.76 |
FAM133B |
family with sequence similarity 133, member B |
23127 |
0.2 |
chr3_105554539_105554819 | 0.76 |
CBLB |
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
33208 |
0.26 |
chr11_5385954_5386105 | 0.76 |
OR51B6 |
olfactory receptor, family 51, subfamily B, member 6 |
13291 |
0.1 |
chr1_222258921_222259072 | 0.76 |
ENSG00000212094 |
. |
72564 |
0.13 |
chr1_201690086_201690483 | 0.75 |
ENSG00000264802 |
. |
1648 |
0.27 |
chr1_85826642_85826793 | 0.75 |
DDAH1 |
dimethylarginine dimethylaminohydrolase 1 |
43463 |
0.13 |
chr18_457195_458136 | 0.74 |
RP11-720L2.2 |
|
33249 |
0.16 |
chr21_46471417_46471568 | 0.74 |
AP001579.1 |
Uncharacterized protein |
21435 |
0.14 |
chr16_18944316_18944467 | 0.74 |
ENSG00000265515 |
. |
2787 |
0.19 |
chr14_52794109_52794643 | 0.73 |
PTGER2 |
prostaglandin E receptor 2 (subtype EP2), 53kDa |
13263 |
0.25 |
chr7_114627811_114627962 | 0.73 |
MDFIC |
MyoD family inhibitor domain containing |
53962 |
0.18 |
chr2_238087157_238087308 | 0.72 |
AC112715.2 |
Uncharacterized protein |
78502 |
0.09 |
chr5_78800078_78800229 | 0.72 |
HOMER1 |
homer homolog 1 (Drosophila) |
8464 |
0.24 |
chr8_13089426_13089577 | 0.72 |
DLC1 |
deleted in liver cancer 1 |
44554 |
0.17 |
chr15_33131575_33131726 | 0.72 |
FMN1 |
formin 1 |
48805 |
0.14 |
chr10_121006994_121007145 | 0.72 |
ENSG00000242853 |
. |
34700 |
0.12 |
chr3_27401993_27402518 | 0.72 |
ENSG00000221573 |
. |
1894 |
0.34 |
chr10_127904378_127904529 | 0.71 |
ENSG00000222740 |
. |
70302 |
0.12 |
chr7_47500601_47500752 | 0.71 |
TNS3 |
tensin 3 |
7847 |
0.33 |
chr12_31061884_31062035 | 0.71 |
TSPAN11 |
tetraspanin 11 |
17403 |
0.26 |
chr5_60699219_60699583 | 0.71 |
ZSWIM6 |
zinc finger, SWIM-type containing 6 |
71301 |
0.12 |
chr2_144711401_144711552 | 0.71 |
AC016910.1 |
|
16836 |
0.25 |
chr9_91268436_91268587 | 0.71 |
ENSG00000265873 |
. |
92309 |
0.09 |
chr11_35121206_35121357 | 0.71 |
AL356215.1 |
|
28934 |
0.15 |
chr12_40448798_40448949 | 0.70 |
SLC2A13 |
solute carrier family 2 (facilitated glucose transporter), member 13 |
50788 |
0.17 |
chr14_59680322_59680595 | 0.70 |
DAAM1 |
dishevelled associated activator of morphogenesis 1 |
25041 |
0.26 |
chr15_72632646_72632797 | 0.70 |
CELF6 |
CUGBP, Elav-like family member 6 |
20251 |
0.14 |
chr8_122273763_122274061 | 0.70 |
ENSG00000221644 |
. |
74780 |
0.12 |
chrX_7252125_7252319 | 0.69 |
STS |
steroid sulfatase (microsomal), isozyme S |
114725 |
0.07 |
chr12_89969123_89969521 | 0.69 |
RP11-981P6.1 |
|
14416 |
0.14 |
chr5_152948760_152948911 | 0.69 |
GRIA1 |
glutamate receptor, ionotropic, AMPA 1 |
77103 |
0.12 |
chr10_11567375_11567526 | 0.69 |
USP6NL |
USP6 N-terminal like |
6824 |
0.3 |
chr14_54468876_54469027 | 0.69 |
BMP4 |
bone morphogenetic protein 4 |
43472 |
0.18 |
chr3_123376529_123376680 | 0.69 |
MYLK-AS2 |
MYLK antisense RNA 2 |
31887 |
0.15 |
chr15_89545625_89545992 | 0.68 |
ENSG00000265866 |
. |
30125 |
0.17 |
chr4_119674096_119674247 | 0.68 |
SEC24D |
SEC24 family member D |
5626 |
0.29 |
chr13_94958048_94958199 | 0.68 |
GPC6-AS1 |
GPC6 antisense RNA 1 |
117878 |
0.06 |
chr9_91428717_91428994 | 0.68 |
ENSG00000265873 |
. |
68035 |
0.13 |
chr1_66806850_66807746 | 0.68 |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
9426 |
0.31 |
chr4_120053097_120053248 | 0.67 |
MYOZ2 |
myozenin 2 |
3767 |
0.3 |
chr20_48564749_48564900 | 0.67 |
ENSG00000239157 |
. |
7887 |
0.13 |
chr11_122542292_122542848 | 0.67 |
UBASH3B |
ubiquitin associated and SH3 domain containing B |
16187 |
0.23 |
chr4_148821069_148821220 | 0.67 |
ARHGAP10 |
Rho GTPase activating protein 10 |
18126 |
0.25 |
chr1_82145942_82146093 | 0.67 |
LPHN2 |
latrophilin 2 |
19438 |
0.25 |
chr3_33104853_33105245 | 0.67 |
GLB1 |
galactosidase, beta 1 |
33235 |
0.13 |
chr3_134078695_134079060 | 0.67 |
AMOTL2 |
angiomotin like 2 |
11877 |
0.22 |
chr14_53509865_53510016 | 0.67 |
RP11-368P15.3 |
|
6467 |
0.27 |
chr14_62214601_62214752 | 0.67 |
SNAPC1 |
small nuclear RNA activating complex, polypeptide 1, 43kDa |
14399 |
0.24 |
chr3_123837060_123837211 | 0.66 |
ENSG00000266383 |
. |
14641 |
0.2 |
chr9_109470744_109470895 | 0.66 |
ENSG00000200131 |
. |
28561 |
0.25 |
chr8_119016065_119016216 | 0.66 |
EXT1 |
exostosin glycosyltransferase 1 |
106513 |
0.08 |
chr8_93064435_93064586 | 0.66 |
RUNX1T1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
10681 |
0.3 |
chr6_139724676_139724827 | 0.66 |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
28994 |
0.23 |
chr3_16551168_16551938 | 0.66 |
RFTN1 |
raftlin, lipid raft linker 1 |
2858 |
0.36 |
chr9_16744814_16744965 | 0.66 |
BNC2 |
basonuclin 2 |
16677 |
0.23 |
chr4_77884504_77884655 | 0.65 |
SEPT11 |
septin 11 |
13564 |
0.23 |
chr2_206595324_206595734 | 0.65 |
AC007362.3 |
|
33148 |
0.2 |
chr10_662236_662387 | 0.65 |
RP11-809C18.3 |
|
12267 |
0.16 |
chr2_38408174_38408471 | 0.65 |
ENSG00000199603 |
. |
33765 |
0.18 |
chr2_18654348_18654499 | 0.65 |
RDH14 |
retinol dehydrogenase 14 (all-trans/9-cis/11-cis) |
87523 |
0.09 |
chr6_43958464_43958740 | 0.65 |
C6orf223 |
chromosome 6 open reading frame 223 |
9715 |
0.17 |
chr12_75708592_75708743 | 0.64 |
CAPS2 |
calcyphosine 2 |
11574 |
0.18 |
chr8_121680676_121680965 | 0.64 |
RP11-713M15.1 |
|
92673 |
0.09 |
chr5_143268458_143268609 | 0.64 |
HMHB1 |
histocompatibility (minor) HB-1 |
76807 |
0.12 |
chr8_28024028_28024179 | 0.64 |
ELP3 |
elongator acetyltransferase complex subunit 3 |
7988 |
0.25 |
chr2_191728576_191729109 | 0.64 |
GLS |
glutaminase |
16711 |
0.2 |
chrX_99902890_99903180 | 0.64 |
SRPX2 |
sushi-repeat containing protein, X-linked 2 |
3820 |
0.21 |
chr14_55092226_55092377 | 0.64 |
SAMD4A |
sterile alpha motif domain containing 4A |
57664 |
0.14 |
chr21_38512491_38512642 | 0.64 |
TTC3 |
tetratricopeptide repeat domain 3 |
4294 |
0.2 |
chr17_37156604_37156755 | 0.63 |
LRRC37A11P |
leucine rich repeat containing 37, member A11, pseudogene |
26851 |
0.12 |
chr20_6514129_6514280 | 0.63 |
BMP2 |
bone morphogenetic protein 2 |
234107 |
0.02 |
chr18_25621201_25621352 | 0.63 |
CDH2 |
cadherin 2, type 1, N-cadherin (neuronal) |
4284 |
0.35 |
chr4_2331381_2331532 | 0.63 |
ENSG00000239247 |
. |
13223 |
0.15 |
chr1_92178896_92179392 | 0.63 |
ENSG00000239794 |
. |
116487 |
0.06 |
chr2_139122947_139123098 | 0.62 |
SPOPL |
speckle-type POZ protein-like |
136349 |
0.05 |
chr7_134620142_134620293 | 0.62 |
CALD1 |
caldesmon 1 |
14980 |
0.24 |
chr5_126412858_126413009 | 0.62 |
C5orf63 |
chromosome 5 open reading frame 63 |
3749 |
0.32 |
chr20_36536392_36536543 | 0.62 |
VSTM2L |
V-set and transmembrane domain containing 2 like |
4923 |
0.26 |
chr5_163629611_163629762 | 0.62 |
CTC-340A15.2 |
|
94016 |
0.1 |
chr9_127483431_127483582 | 0.62 |
ENSG00000207737 |
. |
27517 |
0.12 |
chr7_147110420_147110571 | 0.62 |
ENSG00000221442 |
. |
35282 |
0.24 |
chr6_2397395_2397546 | 0.62 |
ENSG00000266252 |
. |
12399 |
0.3 |
chr6_112576477_112576628 | 0.62 |
LAMA4 |
laminin, alpha 4 |
411 |
0.85 |
chr5_148895303_148895454 | 0.61 |
CSNK1A1 |
casein kinase 1, alpha 1 |
2594 |
0.26 |
chr1_186472737_186472888 | 0.61 |
PDC |
phosducin |
42558 |
0.15 |
chr6_140076091_140076242 | 0.61 |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
380409 |
0.01 |
chr3_106438771_106438922 | 0.61 |
ENSG00000200361 |
. |
31321 |
0.26 |
chr11_47945824_47946190 | 0.61 |
PTPRJ |
protein tyrosine phosphatase, receptor type, J |
56106 |
0.11 |
chr10_63765570_63765875 | 0.61 |
ARID5B |
AT rich interactive domain 5B (MRF1-like) |
43248 |
0.18 |
chr8_122634312_122634612 | 0.61 |
HAS2-AS1 |
HAS2 antisense RNA 1 |
17071 |
0.22 |
chr1_96831244_96831395 | 0.60 |
ENSG00000200800 |
. |
139862 |
0.05 |
chr2_32711035_32711186 | 0.60 |
ENSG00000207653 |
. |
46110 |
0.15 |
chr9_79065617_79065768 | 0.60 |
GCNT1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
8376 |
0.27 |
chr14_80064218_80064369 | 0.60 |
RP11-242P2.2 |
|
35361 |
0.24 |
chr12_42958679_42958830 | 0.60 |
PRICKLE1 |
prickle homolog 1 (Drosophila) |
24724 |
0.21 |
chr18_22811436_22811645 | 0.60 |
ZNF521 |
zinc finger protein 521 |
46 |
0.99 |
chr3_112485838_112485989 | 0.60 |
ENSG00000242770 |
. |
35412 |
0.18 |
chr2_204491651_204491802 | 0.60 |
CD28 |
CD28 molecule |
79472 |
0.1 |
chr5_32599881_32600032 | 0.60 |
SUB1 |
SUB1 homolog (S. cerevisiae) |
14250 |
0.26 |
chr21_30547826_30547977 | 0.60 |
ENSG00000212479 |
. |
5059 |
0.14 |
chr13_110896910_110897061 | 0.60 |
COL4A2 |
collagen, type IV, alpha 2 |
61174 |
0.13 |
chr7_100143800_100144652 | 0.60 |
AGFG2 |
ArfGAP with FG repeats 2 |
7344 |
0.09 |
chr1_235099398_235100350 | 0.60 |
ENSG00000239690 |
. |
59941 |
0.14 |
chr2_42291464_42291615 | 0.60 |
PKDCC |
protein kinase domain containing, cytoplasmic |
16379 |
0.21 |
chr8_59780370_59780521 | 0.60 |
ENSG00000201231 |
. |
53334 |
0.16 |
chr15_102215756_102215907 | 0.60 |
ENSG00000238502 |
. |
7887 |
0.16 |
chr3_99580432_99580636 | 0.60 |
FILIP1L |
filamin A interacting protein 1-like |
10615 |
0.25 |
chr10_79150908_79151184 | 0.60 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
12696 |
0.23 |
chr5_39716970_39717121 | 0.60 |
DAB2 |
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
254643 |
0.02 |
chr15_74906801_74907591 | 0.59 |
CLK3 |
CDC-like kinase 3 |
26 |
0.93 |
chr10_44757120_44757342 | 0.59 |
RP11-20J15.3 |
|
31926 |
0.23 |
chr21_28794987_28795138 | 0.59 |
ADAMTS5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
456230 |
0.01 |
chr9_4689321_4689472 | 0.59 |
CDC37L1 |
cell division cycle 37-like 1 |
9830 |
0.17 |
chr3_64207151_64207437 | 0.59 |
PRICKLE2 |
prickle homolog 2 (Drosophila) |
3837 |
0.26 |
chr13_60524304_60524455 | 0.59 |
DIAPH3-AS1 |
DIAPH3 antisense RNA 1 |
62506 |
0.14 |
chr5_77935014_77935165 | 0.59 |
LHFPL2 |
lipoma HMGIC fusion partner-like 2 |
9559 |
0.31 |
chr5_33032085_33032236 | 0.59 |
AC026703.1 |
|
243215 |
0.02 |
chr2_238357915_238358414 | 0.59 |
AC112721.1 |
Uncharacterized protein |
24245 |
0.16 |
chr16_72928092_72928381 | 0.59 |
ENSG00000251868 |
. |
72345 |
0.09 |
chr5_35781262_35781797 | 0.59 |
SPEF2 |
sperm flagellar 2 |
2259 |
0.35 |
chr1_28297303_28297454 | 0.59 |
RP11-460I13.2 |
|
10674 |
0.13 |
chr13_49881771_49881922 | 0.59 |
CAB39L |
calcium binding protein 39-like |
43417 |
0.15 |
chr12_57703986_57704137 | 0.59 |
R3HDM2 |
R3H domain containing 2 |
185 |
0.93 |
chr6_134317387_134317538 | 0.59 |
TBPL1 |
TBP-like 1 |
43100 |
0.15 |
chr12_43188282_43188433 | 0.59 |
PRICKLE1 |
prickle homolog 1 (Drosophila) |
204200 |
0.03 |
chr6_155593827_155593978 | 0.58 |
CLDN20 |
claudin 20 |
8755 |
0.2 |
chr5_43208877_43209028 | 0.58 |
NIM1K |
NIM1 serine/threonine protein kinase |
15998 |
0.21 |
chr8_131146422_131146573 | 0.58 |
ASAP1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 |
15729 |
0.2 |
chr6_143162950_143163341 | 0.58 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
4961 |
0.32 |
chr6_84910984_84911266 | 0.58 |
KIAA1009 |
KIAA1009 |
26189 |
0.27 |
chr6_155387487_155387638 | 0.58 |
TIAM2 |
T-cell lymphoma invasion and metastasis 2 |
23861 |
0.25 |
chr8_119559085_119559376 | 0.58 |
SAMD12 |
sterile alpha motif domain containing 12 |
33891 |
0.25 |
chr3_172038846_172038997 | 0.58 |
AC092964.1 |
Uncharacterized protein |
4703 |
0.25 |
chr12_51126249_51126400 | 0.58 |
ENSG00000200428 |
. |
11027 |
0.19 |
chr9_97555027_97555178 | 0.58 |
C9orf3 |
chromosome 9 open reading frame 3 |
7356 |
0.2 |
chr12_24191758_24191909 | 0.58 |
SOX5 |
SRY (sex determining region Y)-box 5 |
87867 |
0.1 |
chr15_33121137_33121288 | 0.58 |
FMN1 |
formin 1 |
59243 |
0.11 |
chr3_99419845_99419996 | 0.58 |
ENSG00000263810 |
. |
9505 |
0.27 |
chr13_28904109_28904391 | 0.58 |
FLT1 |
fms-related tyrosine kinase 1 |
7480 |
0.28 |
chr2_85403296_85403447 | 0.58 |
TCF7L1-IT1 |
TCF7L1 intronic transcript 1 (non-protein coding) |
10161 |
0.17 |
chr3_159570147_159570391 | 0.58 |
SCHIP1 |
schwannomin interacting protein 1 |
459 |
0.83 |
chr18_55435741_55435892 | 0.57 |
ENSG00000202159 |
. |
13190 |
0.19 |
chr4_26017394_26017545 | 0.57 |
SMIM20 |
small integral membrane protein 20 |
101538 |
0.08 |
chr13_25848465_25848616 | 0.57 |
MTMR6 |
myotubularin related protein 6 |
13164 |
0.17 |
chr2_218529536_218529687 | 0.57 |
DIRC3 |
disrupted in renal carcinoma 3 |
91667 |
0.09 |
chr15_89658996_89659147 | 0.57 |
ENSG00000239151 |
. |
4939 |
0.2 |
chr2_33662966_33663243 | 0.57 |
RASGRP3 |
RAS guanyl releasing protein 3 (calcium and DAG-regulated) |
1713 |
0.48 |
chr1_8155236_8155387 | 0.57 |
ERRFI1 |
ERBB receptor feedback inhibitor 1 |
68943 |
0.1 |
chr13_32708450_32708601 | 0.57 |
FRY |
furry homolog (Drosophila) |
73524 |
0.11 |
chr6_11425811_11425962 | 0.57 |
NEDD9 |
neural precursor cell expressed, developmentally down-regulated 9 |
43305 |
0.17 |
chr12_110463458_110463609 | 0.57 |
ANKRD13A |
ankyrin repeat domain 13A |
2830 |
0.25 |
chr6_56706459_56706925 | 0.57 |
DST |
dystonin |
1251 |
0.46 |
chr4_2869972_2870216 | 0.57 |
ADD1 |
adducin 1 (alpha) |
7529 |
0.2 |
chr9_16826598_16826749 | 0.57 |
BNC2 |
basonuclin 2 |
5613 |
0.32 |
chr8_97108986_97109137 | 0.57 |
GDF6 |
growth differentiation factor 6 |
63959 |
0.13 |
chr5_121425110_121425261 | 0.56 |
LOX |
lysyl oxidase |
11205 |
0.21 |
chr3_16392047_16392198 | 0.56 |
RP11-415F23.4 |
|
5489 |
0.2 |
chr2_238163338_238163489 | 0.56 |
AC112715.2 |
Uncharacterized protein |
2321 |
0.4 |
chr2_58108331_58108482 | 0.56 |
VRK2 |
vaccinia related kinase 2 |
26380 |
0.27 |
chr6_132259402_132259553 | 0.56 |
RP11-69I8.3 |
|
12609 |
0.21 |
chr3_45949031_45949182 | 0.56 |
ENSG00000201635 |
. |
4427 |
0.17 |
chr2_118981232_118982329 | 0.56 |
INSIG2 |
insulin induced gene 2 |
135730 |
0.05 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.5 | 1.4 | GO:1900116 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.4 | 1.7 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.4 | 1.8 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.4 | 1.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.4 | 0.4 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.3 | 1.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 1.3 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 0.9 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.3 | 1.7 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.3 | 1.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.3 | 0.8 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.3 | 0.8 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.3 | 0.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.3 | 0.3 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.2 | 0.7 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.2 | 0.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.7 | GO:0044413 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.2 | 0.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 1.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 1.3 | GO:0031641 | regulation of myelination(GO:0031641) |
0.2 | 0.6 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.2 | 0.6 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.2 | 0.6 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.2 | 0.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 0.6 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.5 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.2 | 0.4 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.2 | 0.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 0.5 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.2 | 0.9 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 0.7 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.2 | 0.7 | GO:0070141 | response to UV-A(GO:0070141) |
0.2 | 0.7 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.2 | 0.7 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.2 | 0.5 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.2 | 0.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 1.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.2 | 0.5 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.2 | 0.6 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 0.5 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.2 | 0.2 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.2 | 0.6 | GO:0002669 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.1 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.1 | 0.1 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.4 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 1.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.4 | GO:0034653 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.6 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.1 | 0.7 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.1 | 0.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.4 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.4 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 0.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.9 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.9 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.1 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 0.4 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 1.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.5 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 1.2 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.8 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 1.3 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.1 | 2.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.2 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.2 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.2 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.1 | 0.3 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.1 | 2.8 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.3 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.4 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.1 | 0.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 1.6 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.1 | 0.2 | GO:0032825 | regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.6 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.4 | GO:0060754 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.1 | 0.3 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.4 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.2 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.1 | 0.2 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.1 | 0.2 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.1 | 0.3 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 | 1.6 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.1 | 0.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.1 | GO:0072133 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.1 | 0.2 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.1 | GO:0010716 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.3 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.4 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.1 | 0.1 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.4 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.1 | GO:0042520 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.1 | 0.3 | GO:0032344 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.1 | 0.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.3 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.1 | 0.3 | GO:0070091 | glucagon secretion(GO:0070091) |
0.1 | 0.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.2 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.1 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.1 | 0.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.3 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.6 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.2 | GO:1903672 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 0.2 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.4 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.4 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.7 | GO:0010092 | organ induction(GO:0001759) specification of organ identity(GO:0010092) |
0.1 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.3 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.1 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.1 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 0.2 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.1 | 0.1 | GO:0046639 | negative regulation of alpha-beta T cell differentiation(GO:0046639) |
0.1 | 0.5 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.1 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.3 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.5 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.3 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.1 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.1 | 0.5 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.8 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.1 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.6 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.1 | 0.2 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.1 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.4 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.6 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.1 | 0.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.1 | 0.3 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.5 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.1 | 0.4 | GO:0044065 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) regulation of respiratory system process(GO:0044065) |
0.1 | 0.2 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 0.1 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.1 | 0.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.2 | GO:0035929 | steroid hormone secretion(GO:0035929) |
0.1 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.4 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.6 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.1 | 0.2 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.1 | 0.5 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.1 | 0.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.7 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.2 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.1 | 0.2 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.1 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.1 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.1 | 0.1 | GO:0060004 | reflex(GO:0060004) |
0.1 | 0.4 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.1 | 0.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.3 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.3 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.3 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.0 | 0.5 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.0 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.7 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.6 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.2 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.1 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.0 | 0.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.8 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.0 | 0.1 | GO:2000300 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.0 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.1 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.0 | 0.2 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.0 | 0.1 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.0 | 0.1 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
0.0 | 0.1 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.5 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.0 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.0 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.1 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.1 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.0 | 0.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.0 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.0 | 0.0 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.0 | 0.2 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.3 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.0 | GO:0060911 | cardiac cell fate commitment(GO:0060911) |
0.0 | 0.1 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.0 | 0.2 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.3 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.2 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.0 | GO:0032634 | interleukin-5 production(GO:0032634) regulation of interleukin-5 production(GO:0032674) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0031650 | regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
0.0 | 0.2 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.0 | 0.1 | GO:0051461 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.1 | GO:0090559 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.0 | 0.0 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 0.5 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.1 | GO:0032413 | negative regulation of ion transmembrane transporter activity(GO:0032413) |
0.0 | 0.2 | GO:0061515 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.0 | 0.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.1 | GO:0014032 | neural crest cell development(GO:0014032) |
0.0 | 0.1 | GO:0061687 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.0 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 1.5 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.4 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.1 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.1 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.0 | 0.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.2 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.0 | 0.3 | GO:0006853 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.0 | 0.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.1 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.0 | 0.2 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.1 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.0 | GO:0003079 | obsolete positive regulation of natriuresis(GO:0003079) |
0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.1 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.0 | 0.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.0 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.0 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.0 | 0.1 | GO:0010269 | response to selenium ion(GO:0010269) |
0.0 | 0.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.1 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.0 | 0.1 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.0 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.0 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.0 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.8 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.1 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.0 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.3 | GO:0050879 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
0.0 | 0.2 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.0 | 0.1 | GO:0001975 | response to amphetamine(GO:0001975) |
0.0 | 0.1 | GO:0048747 | muscle fiber development(GO:0048747) |
0.0 | 0.1 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.0 | 0.0 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.0 | 0.1 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.0 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.0 | 0.0 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.0 | 0.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.0 | GO:2000316 | T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) T-helper 17 type immune response(GO:0072538) T-helper 17 cell differentiation(GO:0072539) T-helper 17 cell lineage commitment(GO:0072540) regulation of T-helper 17 type immune response(GO:2000316) positive regulation of T-helper 17 type immune response(GO:2000318) regulation of T-helper 17 cell differentiation(GO:2000319) positive regulation of T-helper 17 cell differentiation(GO:2000321) regulation of T-helper 17 cell lineage commitment(GO:2000328) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
0.0 | 0.1 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.4 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.0 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.1 | GO:0045007 | depurination(GO:0045007) |
0.0 | 0.1 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.4 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:1901796 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) regulation of signal transduction by p53 class mediator(GO:1901796) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.1 | GO:0000239 | pachytene(GO:0000239) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.1 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 0.1 | GO:0032811 | regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) |
0.0 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.0 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.0 | 0.0 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.0 | 0.0 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.0 | 0.1 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.0 | 0.1 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.1 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.1 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.0 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.0 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.0 | GO:0022605 | oogenesis stage(GO:0022605) |
0.0 | 0.0 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.0 | 0.1 | GO:0015838 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.0 | 0.1 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.0 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.2 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.0 | GO:0034650 | cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
0.0 | 0.0 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.0 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.1 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.2 | GO:0006195 | purine nucleotide catabolic process(GO:0006195) |
0.0 | 0.0 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.0 | 0.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.0 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.0 | 0.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.0 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.0 | 0.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.0 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.0 | 0.0 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 1.9 | GO:0006936 | muscle contraction(GO:0006936) |
0.0 | 0.0 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.1 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.0 | 0.0 | GO:0021819 | cerebral cortex radial glia guided migration(GO:0021801) layer formation in cerebral cortex(GO:0021819) telencephalon glial cell migration(GO:0022030) |
0.0 | 0.0 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.6 | GO:0007631 | feeding behavior(GO:0007631) |
0.0 | 0.0 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.0 | 0.0 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.1 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.0 | 0.1 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.0 | GO:0051597 | response to methylmercury(GO:0051597) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.0 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.0 | GO:0014075 | response to amine(GO:0014075) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 0.0 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.0 | 0.0 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.0 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.0 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.0 | 0.1 | GO:0071675 | regulation of macrophage chemotaxis(GO:0010758) positive regulation of macrophage chemotaxis(GO:0010759) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.0 | 0.0 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.0 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.0 | 0.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.1 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.0 | 0.0 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.0 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.0 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.0 | 0.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.0 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.0 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.0 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.0 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.0 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.0 | GO:0016139 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.2 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.3 | 1.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 0.8 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.2 | 1.7 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.2 | 1.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 1.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.2 | 1.6 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 0.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 1.9 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 0.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 0.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 1.1 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.1 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 0.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.5 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 1.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.8 | GO:0002102 | podosome(GO:0002102) |
0.1 | 2.8 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.6 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 1.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.3 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.8 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.3 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 1.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 6.7 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 0.2 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.2 | GO:0043256 | laminin complex(GO:0043256) |
0.1 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 2.4 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 1.1 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 1.4 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.3 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 1.7 | GO:0044309 | neuron spine(GO:0044309) |
0.0 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 10.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 2.2 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.3 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.0 | 0.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 2.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.1 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.3 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.1 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.0 | 0.2 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.0 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.1 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.3 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.0 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.3 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.0 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.8 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.0 | 0.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.0 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.4 | 1.1 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.4 | 1.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 1.4 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.3 | 0.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 0.8 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.3 | 0.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 0.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 1.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 1.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 3.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 2.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 0.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 1.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.6 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.2 | 0.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 0.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 1.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.5 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 0.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.5 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 0.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 0.6 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.7 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.1 | 0.4 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.8 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.1 | 2.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.5 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.6 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 1.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 4.6 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.7 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.1 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 1.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 1.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.6 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.3 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.9 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.5 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.7 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.4 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 1.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.6 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.2 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.1 | 0.5 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 1.3 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.2 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.1 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.1 | 1.0 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.3 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 0.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.7 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.1 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 3.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.3 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.2 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 1.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.2 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.2 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.1 | 0.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.4 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.2 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.0 | 0.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.3 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.2 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.1 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.4 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.0 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.1 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.0 | 0.3 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.3 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.3 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 0.4 | GO:0005035 | death receptor activity(GO:0005035) |
0.0 | 0.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.2 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.0 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 0.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 1.1 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.1 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.2 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.1 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.0 | GO:0030354 | melanin-concentrating hormone activity(GO:0030354) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.2 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.0 | 0.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.1 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.1 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.0 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.5 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.0 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.0 | 0.0 | GO:0046978 | peptide-transporting ATPase activity(GO:0015440) TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.0 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.0 | 0.2 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.0 | 0.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.0 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.0 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.0 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.0 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 0.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 2.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 5.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 1.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 2.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 7.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 1.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.4 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 5.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 2.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 1.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 0.2 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.1 | 0.3 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 1.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 5.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 2.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.8 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.6 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 0.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.3 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.3 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.2 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.0 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 1.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |